Ginkgo Bioworks Holdings (DNA) Interest Expenses (2019 - 2026)

Ginkgo Bioworks Holdings' Interest Expenses history runs 8 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• Quarterly Interest Expenses rose 8.24% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (up 8.24% YoY) and the FY2025 annual result came in at $840.1 million, up 8.84% from the prior year.
• Interest Expenses was $2.9 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $840.1 million in the prior quarter.
• Across five years, Interest Expenses topped out at $840.1 million in Q4 2025 and bottomed at -$15.0 million in Q3 2023.
• A 5-year average of $163.7 million and a median of $37.9 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses jumped 151095.28% — and 2023, when it plunged 129.51%.
• Ginkgo Bioworks Holdings' Interest Expenses stood at $833.1 million in 2022, then sank by 89.44% to $88.0 million in 2023, then slumped by 64.34% to $31.4 million in 2024, then jumped by 2577.99% to $840.1 million in 2025, then plunged by 99.65% to $2.9 million in 2026.
• Business Quant data shows DNA's Interest Expenses at $2.9 million in Q1 2026, $840.1 million in Q4 2025, and $3.0 million in Q3 2025.